Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Feb 1;29(2):785-804.
doi: 10.3390/curroncol29020067.

Feasibility, Acceptability, and Clinical Significance of a Dyadic, Web-Based, Psychosocial and Physical Activity Self-Management Program (TEMPO) Tailored to the Needs of Men with Prostate Cancer and Their Caregivers: A Multi-Center Randomized Pilot Trial

Sylvie D Lambert  1   2 , Lindsay R Duncan  3 , S Nicole Culos-Reed  4   5 , Laura Hallward  3 , Celestia S Higano  6 , Ekaterina Loban  1   7 , Anne Katz  8 , Manon De Raad  1 , Janet Ellis  9 , Melissa B Korman  10 , Carly Sears  11 , Cindy Ibberson  1 , Lauren Walker  12 , Eric Belzile  1 , Paramita Saha-Chaudhuri  13 , Helen McTaggart-Cowan  14 , Stuart Peacock  14
Affiliations
Randomized Controlled Trial

Feasibility, Acceptability, and Clinical Significance of a Dyadic, Web-Based, Psychosocial and Physical Activity Self-Management Program (TEMPO) Tailored to the Needs of Men with Prostate Cancer and Their Caregivers: A Multi-Center Randomized Pilot Trial

Sylvie D Lambert et al. Curr Oncol. .

Abstract

Background: Prostate cancer is the most common cancer diagnosis among men. Family caregivers (often female spouses) play a key role in ensuring patients' needs are met, frequently assuming their role with no formal training, which can contribute to a high burden. The purpose of this study was to pilot TEMPO-the first dyadic, Tailored, wEb-based, psychosocial and physical activity self-Management PrOgram for men with prostate cancer and their caregivers.

Methods: 49 men with prostate cancer and their caregivers were randomized to TEMPO or usual care. Baseline and follow-up questionnaires were completed to assess feasibility, acceptability, and clinical significance. A priori benchmarks for these outcomes were set. Thirteen exit interviews were conducted to further explore acceptability.

Results: Feasibility benchmarks were met with the exception for recruitment with on average 6.1 dyads recruited/month (benchmark: 8 dyads/month). Benchmarks of acceptability focused on attrition (<25%) and system usability, which were met. Using the strict criteria for adherence of 100% of the module viewed and participants spending at least 15 min on the module, 45% of participants were adherent. The clinical significance on anxiety and quality of life was supported for caregivers, and mostly supported for the men with prostate cancer.

Conclusion: This pilot trial was successful, with minor modifications needed prior to a large trial.

Keywords: behavior change; caregivers; dyadic interventions; dyads; e-Health interventions; physical activity; pilot study; prostate cancer; psychosocial needs; self-management.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design, execution, interpretation, or writing of the study.

Figures

Figure 1
Figure 1
Flow diagram of recruitment and enrollment in TEMPO.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Canadian Cancer Society’s Advisory Committee on Cancer Statistics . Canadian Cancer Statistics 2016. Canadian Cancer Society; Toronto, ON, Canada: 2016.
    1. Msaouel P., Gralla R.J., Jones R.A., Hollen P.J. Key issues affecting quality of life and patient-reported outcomes in prostate cancer: An analysis conducted in 2128 patients with initial psychometric assessment of the prostate cancer symptom scale (PCSS) BMJ Support. Palliat. Care. 2017;7:308–315. doi: 10.1136/bmjspcare-2016-001146. - DOI - PMC - PubMed
    1. Regan T.W., Lambert S.D., Kelly B., McElduff P., Girgis A., Kayser K., Turner J. Cross-sectional relationships between dyadic coping and anxiety, depression, and relationship satisfaction for patients with prostate cancer and their spouses. Patient Educ. Couns. 2014;96:120–127. doi: 10.1016/j.pec.2014.04.010. - DOI - PubMed
    1. Isbarn H., Boccon-Gibod L., Carroll P.R., Montorsi F., Schulman C., Smith M.R., Sternberg C.N., Studer U.E. Androgen Deprivation Therapy for the Treatment of Prostate Cancer: Consider Both Benefits and Risks. Eur. Urol. 2009;55:62–75. doi: 10.1016/j.eururo.2008.10.008. - DOI - PMC - PubMed
    1. Hsiao C.-P., Loescher L.J., Moore I.M.K. Symptoms and Symptom Distress in Localized Prostate Cancer. Cancer Nurs. 2007;30:E19–E32. doi: 10.1097/01.NCC.0000300163.13639.bc. - DOI - PubMed

Publication types